PatientsVille.com Logo

Prophylaxis and Asasantin

PatientsVille

Prophylaxis Symptoms and Causes

In the early 1980s, when the HIV/AIDS epidemic began, patients rarely lived longer than a few years. But today, there are many effective medicines to fight the infection, and people with HIV have longer, healthier lives.

There are five major types of medicines:

  • Reverse transcriptase (RT) inhibitors - interfere with a critical step during the HIV life cycle and keep the virus from making copies of itself
  • Protease inhibitors - interfere with a protein that HIV uses to make infectious viral particles
  • Fusion inhibitors - block the virus from entering the body's cells
  • Integrase inhibitors - block an enzyme HIV needs to make copies of itself
  • Multidrug combinations - combine two or more different types of drugs into one

These medicines help people with HIV, but they are not perfect. They do not cure HIV/AIDS. People with HIV infection still have the virus in their bodies. They can still spread HIV to others through unprotected sex and needle sharing, even when they are taking their medicines.

NIH: National Institute of Allergy and Infectious Diseases

Check out the latest treatments for prophylaxis

prophylaxis treatment research studies

Asasantin clinical trials, surveys and public health registries


Find Drug Side Effect reports



Asasantin Side Effects

Cerebrovascular Accident (15)
Renal Failure (7)
Thrombocytopenia (6)
Gastric Ulcer (6)
Haemoglobin Decreased (6)
Rash Erythematous (5)
Angina Pectoris (4)
Gastrointestinal Haemorrhage (4)
Nausea (4)
Anaemia (4)
Transient Ischaemic Attack (4)
Pyrexia (3)
Eosinophilia (3)
Haematemesis (3)
Vomiting (3)
Nightmare (3)
Blood Urea Increased (2)
Asthenia (2)
Bone Cancer Metastatic (2)
Arthralgia (2)
Hallucination (2)
Haemorrhage (2)
Dizziness (2)
Conjunctivitis (2)
Anxiety (2)
Subdural Haematoma (2)
Pruritus (2)
Abdominal Pain Lower (2)
Tendon Rupture (2)
Neutropenia (2)
Vitamin B12 Deficiency (2)
Lethargy (2)
Leukocytosis (2)
Pulmonary Embolism (1)
Lesion Excision (1)
Jaundice (1)
Vasculitis (1)
Liver Function Test Abnormal (1)
Ulcer Haemorrhage (1)
Urinary Tract Infection (1)
Pulmonary Oedema (1)
Prostate Cancer (1)
Pericardial Effusion (1)
Oesophageal Haemorrhage (1)
Oedema (1)
Presyncope (1)
Myocardial Infarction (1)
Malignant Melanoma (1)
Mucous Membrane Disorder (1)
Malaise (1)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Prophylaxis Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Recruiting Treatment of Supine Hypertension in Autonomic Failure
Condition: Hypertension
Interventions: Drug: Clonidine;   Drug: Nitroglycerin transdermal;   Drug: Dipyridamole/ Aspirin (Aggrenox);   Drug: Desmopressin (DDAVP);   Drug: Sildenafil;   Drug: Nifedipine;   Drug: Hydralazine;   Drug: Hydrochlorothiazide;   Drug: Placebo;   Drug: Bosentan;   Drug: Diltiazem;   Drug: Eplerenone;   Drug: guanfacine;   Dietary Supplement: L-arginine;   Drug: captopril;   Drug: carbidopa;   Drug: losartan;   Drug: metoprolol tartrate;   Drug: nebivolol hydrochloride;   Drug: prazosin hydrochloride;   Drug: tamsulosin hydrochloride;   Other: Head-up tilt.;   Drug: aliskiren;   Other: Local heat stress
Outcome Measures: Decrease in supine systolic blood pressure;   Decrease in pressure natriuresis
2 Recruiting Dipyridamole Assessment for Flare Reduction in Systemic Lupus Erythematosus (SLE)
Condition: Systemic Lupus Erythematosus
Interventions: Drug: extended release dipyridamole 200mg/aspirin 25mg;   Drug: 81mg aspirin
Outcome Measures: British Isles Lupus Assessment Group Responder Index (BICLA);   Time to first flare;   Systemic Responder Index (SRI) 4/5;   Health related quality of life [Lupus Quality of Life (Lupus QoL), Short Form 36v2];   Fatigue (FACIT-fatigue score);   Sleep quality [Pittsburgh Sleep Quality Index (PSQI)];   Depression [Center for Epidemiologic Studies Depression (CES-D) Scale];   Number of Participants with Adverse Events as a Measure of Safety and Tolerability;   SRI component analyses;   Cutaneous Lupus Disease Area and Severity Index (CLASI)
3 Recruiting Patent Foramen Ovale Closure or Anticoagulants Versus Antiplatelet Therapy to Prevent Stroke Recurrence
Conditions: Ischemic Stroke;   Patent Foramen Ovale;   Atrial Septal Aneurysm;   Migraine
Interventions: Drug: aspirin;   Drug: Antivitamins K;   Device: Devices for PFO closure
Outcome Measures: stroke(fatal or not);   Disabling stroke;   Ischemic stroke;   Cerebral haemorrhage;   Ischemic stroke, TIA, or systemic embolism;   Death (all causes);   Vascular death;   Moderate to severe bleeding complications;   Procedural or device complications
4 Unknown  Wake up Symptomatic Stroke - Benefit of Intravenous Clot Busters or Endovascular Intervention
Condition: Stroke
Interventions: Drug: Anti-platelets and statin;   Drug: alteplase;   Procedure: intra arterial intervention
Outcome Measures: Modified Rankin Scale (mRS);   National Institute of Health Stroke Scale (NIHSS);   Thrombolysis In Myocardial Infarction (TIMI) Flow;   Thomboylsis in Cerebral Ischemia (TICI) flow;   symptomatic intracranial Hemorrhage (ICH)